• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

等待肝移植患者和肝移植术后患者管理的具体问题。

Specific issues concerning the management of patients on the waiting list and after liver transplantation.

机构信息

Multivisceral Transplant Unit, University Hospital, Padova, Italy.

Gastroenterology Unit, Department of Internal Medicine, University of Genoa, Ospedale Policlinico San Martino, Genoa, Italy.

出版信息

Liver Int. 2018 Aug;38(8):1338-1362. doi: 10.1111/liv.13755. Epub 2018 May 16.

DOI:10.1111/liv.13755
PMID:29637743
Abstract

The present document is a second contribution collecting the recommendations of an expert panel of transplant hepatologists appointed by the Italian Association for the Study of the Liver (AISF) concerning the management of certain aspects of liver transplantation, including: the issue of prompt referral; the management of difficult candidates; malnutrition; living related liver transplants; hepatocellular carcinoma; and the role of direct acting antiviral agents before and after transplantation. The statements on each topic were approved by participants at the AISF Transplant Hepatology Expert Meeting organized by the Permanent Liver Transplant Commission in Mondello on 12-13 May 2017. They are graded according to the GRADE grading system.

摘要

本文件是第二次贡献,汇集了意大利肝脏研究协会(AISF)任命的移植肝脏专家小组的建议,涉及肝移植某些方面的管理,包括:及时转诊问题;困难候选者的管理;营养不良;活体相关肝移植;肝细胞癌;以及直接作用抗病毒药物在移植前后的作用。每个主题的陈述均经 2017 年 5 月 12 日至 13 日在蒙代洛举行的 AISF 移植肝脏学专家会议的与会者批准。它们根据 GRADE 分级系统进行分级。

相似文献

1
Specific issues concerning the management of patients on the waiting list and after liver transplantation.等待肝移植患者和肝移植术后患者管理的具体问题。
Liver Int. 2018 Aug;38(8):1338-1362. doi: 10.1111/liv.13755. Epub 2018 May 16.
2
Common issues in the management of patients in the waiting list and after liver transplantation.等待名单上的患者及肝移植后患者管理中的常见问题。
Dig Liver Dis. 2017 Mar;49(3):241-253. doi: 10.1016/j.dld.2016.12.027. Epub 2016 Dec 31.
3
[V Consensus Meeting of the Spanish Society for Liver Transplant on high-risk recipients, immunosupression scenarios and management of hepatocarcinoma on the transplant waiting list].[西班牙肝脏移植学会关于高风险受者、免疫抑制方案及移植等待名单上肝癌管理的第五届共识会议]
Gastroenterol Hepatol. 2015 Dec;38(10):600-18. doi: 10.1016/j.gastrohep.2015.06.008. Epub 2015 Sep 26.
4
Skills and requirements of a transplant hepatologist: board certification of the Italian Association for the Study of the Liver (AISF).移植肝脏病学家的技能和要求:意大利肝脏研究协会 (AISF) 的委员会认证。
Dig Liver Dis. 2013 Dec;45(12):992-4. doi: 10.1016/j.dld.2013.04.014. Epub 2013 Jun 28.
5
A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.一种在共同的肝移植等待名单上为肝癌患者和非肝癌患者分配公平性的方法。
J Hepatol. 2014 Feb;60(2):290-7. doi: 10.1016/j.jhep.2013.10.010. Epub 2013 Oct 23.
6
International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Candidates.国际肝移植学会关于肝移植候选者丙型肝炎管理的共识声明
Transplantation. 2017 May;101(5):945-955. doi: 10.1097/TP.0000000000001708.
7
Liver transplantation in Spain.西班牙的肝脏移植
Liver Transpl. 2016 Sep;22(9):1259-64. doi: 10.1002/lt.24484. Epub 2016 Jul 22.
8
Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report.肝癌肝移植治疗的推荐:国际共识会议报告。
Lancet Oncol. 2012 Jan;13(1):e11-22. doi: 10.1016/S1470-2045(11)70175-9. Epub 2011 Oct 31.
9
Donation after cardiac death in the hepatocellular carcinoma patient: Same indication?肝细胞癌患者心源性死亡后的捐赠:适应证相同吗?
Liver Transpl. 2017 Oct;23(S1):S27-S33. doi: 10.1002/lt.24862.
10
Liver transplantation in Germany.德国的肝移植
Liver Transpl. 2016 Aug;22(8):1136-42. doi: 10.1002/lt.24461.

引用本文的文献

1
The evolving concept of conversion surgery for upfront unresectable upper gastrointestinal and hepato-pancreato-biliary cancers: comprehensive review.针对初始不可切除的上消化道及肝胰胆恶性肿瘤的转化性手术的演变概念:综述
BJS Open. 2025 Jul 1;9(4). doi: 10.1093/bjsopen/zraf070.
2
At the earliest: a Hub and Spoke referral and referral-back pilot project increases access to liver transplantation and ensures good long-term care.最早:一个“中心-辐条”式转诊和反向转诊试点项目增加了肝移植的可及性,并确保了良好的长期护理。
Updates Surg. 2025 May 26. doi: 10.1007/s13304-025-02262-6.
3
Liver Transplantation in Chronic Liver Disease and Acute on Chronic Liver Failure- Indication, Timing and Practices.
慢性肝病及慢加急性肝衰竭中的肝移植——指征、时机与实践
J Clin Exp Hepatol. 2024 May-Jun;14(3):101347. doi: 10.1016/j.jceh.2024.101347. Epub 2024 Jan 26.
4
The role of an integrated referral program for patients with liver disease: A network between hub and spoke centers.肝病患者综合转诊计划的作用:枢纽与辐辏中心之间的网络。
United European Gastroenterol J. 2024 Feb;12(1):76-88. doi: 10.1002/ueg2.12475. Epub 2023 Dec 13.
5
Therapeutic Approach to Post-Transplant Recurrence of Hepatocellular Carcinoma: Certainties and Open Issues.肝细胞癌移植后复发的治疗方法:确定因素与未决问题
Cancers (Basel). 2023 Nov 26;15(23):5593. doi: 10.3390/cancers15235593.
6
Liver Transplantation in Patients with Hepatocellular Carcinoma beyond the Milan Criteria: A Comprehensive Review.米兰标准以外的肝细胞癌患者的肝移植:一项全面综述。
J Clin Med. 2021 Aug 31;10(17):3932. doi: 10.3390/jcm10173932.
7
Low serum magnesium concentration is associated with the presence of viable hepatocellular carcinoma tissue in cirrhotic patients.血清镁浓度低与肝硬化患者存在有活力的肝细胞癌组织有关。
Sci Rep. 2021 Jul 26;11(1):15184. doi: 10.1038/s41598-021-94509-6.
8
Direct-Acting Antiviral Drugs and Occurrence of Hepatocellular Carcinoma: Unjust or Oppressed.直接作用抗病毒药物与肝细胞癌的发生:是不公还是受压迫?
Infect Drug Resist. 2020 Jun 18;13:1873-1880. doi: 10.2147/IDR.S241948. eCollection 2020.
9
The Analysis of Food Intake in Patients with Cirrhosis Waiting for Liver Transplantation: A Neglected Step in the Nutritional Assessment.肝硬化等待肝移植患者的饮食摄入分析:营养评估中被忽视的步骤。
Nutrients. 2019 Oct 15;11(10):2462. doi: 10.3390/nu11102462.